To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
Clinical trial NCT06866509 · COMPLETED
Trial details
- NCT number
- NCT06866509
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-28
- Primary completion
- 2023-12-31
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.